Mario Matthaei
Kerpener Street 62
Koeln, NW 50937, Germany
Koeln, NW 50937, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 90 publications
Delphi-Based Global Consensus on Fuchs Endothelial Corneal Dystrophy. An Endothelial Keratoplasty Learners Group Initiative.
Journal: American journal of ophthalmology
Published: March 09, 2025
Innovative surgical treatment approaches for endothelial dysfunction : Descemet stripping only (DSO) and endothelial cell injection
Journal: Die Ophthalmologie
Published: August 07, 2024
Pathogenesis of Fuchs endothelial corneal dystrophy, the fibrillar layer and individualized treatment
Journal: Die Ophthalmologie
Published: July 08, 2024
Artificial Intelligence for Lamellar Keratoplasty.
Journal: Klinische Monatsblatter fur Augenheilkunde
Published: March 19, 2024
The influence of obesity, diabetes mellitus and smoking on fuchs endothelial corneal dystrophy (FECD).
Journal: Scientific reports
Published: January 21, 2024
Influence of Donor Factors on Descemet Membrane Endothelial Keratoplasty (DMEK) Graft Preparation Outcome.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: November 19, 2023
A Novel Symptomatic Lecithin-Cholesterol Acyltransferase Gene Mutation With Corneal Amyloidosis.
Journal: Cornea
Published: October 18, 2023
Implementation and Execution of Big Data-based Studies in Ophthalmology within the Framework of the GDPR.
Journal: Klinische Monatsblatter fur Augenheilkunde
Published: September 04, 2023
Allogeneic limbo-deep anterior lamellar keratoplasty (Limbo-DALK)-A novel surgical technique in corneal stromal disease and limbal stem cell deficiency.
Journal: PloS one
Published: July 23, 2023
Corneal Infantile Myofibromatosis Caused by Novel Activating Imatinib-Responsive Variants in PDGFRB.
Corneal Infantile Myofibromatosis Caused by Novel Activating Imatinib-Responsive Variants in PDGFRB.
Journal: Ophthalmology science
Published: June 16, 2023
Last Updated: 09/26/2026